Clinical Trial Update: High Dose Trial in COPD [Phase 2]

View source ↗

Summary

This update reports the completion of a phase 2 high-dose trial in chronic obstructive pulmonary disease sponsored by Boehringer Ingelheim.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED